Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19
- PMID: 32624192
- PMCID: PMC7282769
- DOI: 10.1016/j.amjcard.2020.06.003
Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19
Comment on
-
Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019.Am J Cardiol. 2020 Aug 1;128:147-150. doi: 10.1016/j.amjcard.2020.04.054. Epub 2020 May 16. Am J Cardiol. 2020. PMID: 32425199 Free PMC article. Review.
References
-
- Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, Mourão MP.G, Brito-Sousa JD, Baía-da-Silva D, Guerra MVF, Hajjar LA. Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial. JAMA Network Open. 2020;3(4) doi: 10.1001/jamanetworkopen.2020.8857. - DOI - PubMed
-
- Gautret P, Lagier JC, Parola P, Meddeb L, Sevestre J, Mailhe M, Doudier B, Aubry C, Amrane S, Seng P, Hocquart M. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study. Travel Med Infect Dis. 2020 doi: 10.1016/j.tmaid.2020.101663. - DOI - PMC - PubMed
-
- Bessière F, Roccia H, Delinière A, Charrière R, Chevalier P, Argaud L, Cour M. Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit. JAMA Cardiol. 2020;1 doi: 10.1001/jamacardio.2020.1787. Published online May. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
